Literature DB >> 16963822

Four-premolar extraction treatment with Invisalign.

W Randol Womack1.   

Abstract

Mesh：

Year:  2006        PMID： 16963822

Source DB:  PubMed          Journal:  J Clin Orthod        ISSN： 0022-3875


× No keyword cloud information.
  7 in total

1.  The effectiveness of the Invisalign appliance in extraction cases using the the ABO model grading system: a multicenter randomized controlled trial.

Authors:  Weihong Li; Shimei Wang; Yanzhen Zhang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Clear aligners for maxillary anterior en masse retraction: a 3D finite element study.

Authors:  Ting Jiang; Rui Ying Wu; Jian Kai Wang; Hong Hong Wang; Guo Hua Tang
Journal:  Sci Rep       Date:  2020-06-23       Impact factor: 4.379

3.  Class II subdivision correction with clear aligners using intermaxilary elastics.

Authors:  Luca Lombardo; Anna Colonna; Antonella Carlucci; Teresa Oliverio; Giuseppe Siciliani
Journal:  Prog Orthod       Date:  2018-09-01       Impact factor: 2.750

4.  Clinical effectiveness of Invisalign® orthodontic treatment: a systematic review.

Authors:  Aikaterini Papadimitriou; Sophia Mousoulea; Nikolaos Gkantidis; Dimitrios Kloukos
Journal:  Prog Orthod       Date:  2018-09-28       Impact factor: 2.750

5.  Buccolingual Inclination Control of Upper Central Incisors of Aligners: A Comparison with Conventional and Self-Ligating Brackets.

Authors:  Maria Francesca Sfondrini; Paola Gandini; Tommaso Castroflorio; Francesco Garino; Luca Mergati; Krizia D'Anca; Federico Trovati; Andrea Scribante
Journal:  Biomed Res Int       Date:  2018-11-29       Impact factor: 3.411

6.  Force changes associated with differential activation of en-masse retraction and/or intrusion with clear aligners.

Authors:  Ye Zhu; Wei Hu; Shuo Li
Journal:  Korean J Orthod       Date:  2021-01-15       Impact factor: 1.372

Review 7.  Nanoparticles for antiparasitic drug delivery.

Authors:  Yuzhu Sun; Dongmei Chen; Yuanhu Pan; Wei Qu; Haihong Hao; Xu Wang; Zhenli Liu; Shuyu Xie
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.